LUNGevity Foundation is pleased to offer five lung cancer translational research award programs in 2022:

  • LUNGevity’s Career Development Award Program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas. Research that will be funded in 2022 is expected to have a direct impact on the early detection of lung cancer and/or individualized lung cancer treatment, including through targeted therapy and immunotherapy.
     

 

  • LUNGevity’s Veterans Affairs Research Scholar Award Program supports fellows or junior faculty interested in lung cancer research within the Department of Veterans Affairs. Projects that will be funded in 2022 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment. In addition, the proposed research must have relevance to the veteran population, related to either screening/early detection of lung cancer or treatment. This is a mentored award.
     

 

  • LUNGevity’s Pierre Massion Young Investigator Award for Early Detection Research is a new award that will support a young investigator from underrepresented minorities in STEM who is interested in early detection of lung cancer. Applicants must hold a doctoral degree, be within the first five years of their first faculty appointment, and have completed a training fellowship. This is a one-year mentored award.
     

 

  • LUNGevity’s Health Equity and Inclusiveness Junior Investigator Award Program supports physician-scientists interested in conducting lung cancer clinical research and bridging health disparities by engaging underserved communities or underrepresented minorities. Projects that will be funded in 2022 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment.
     

 

  • LUNGevity’s Health Equity and Inclusiveness Research Fellow Award Program supports fellows interested in translational lung cancer research who belong to underrepresented minorities in STEM. Projects that will be funded in 2022 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment. This is a mentored award.